JP7560945B2 - Liquid medicine container display - Google Patents

Description

The present invention relates to a display for displaying liquid medicine containers.

Conventionally, various display items have been known in which liquid medicine containers such as fragrances are packaged for display in stores. Typically, the liquid medicine container is housed in a blister container made of synthetic resin, which is then attached to a mount. The blister container is formed to be transparent, allowing the liquid medicine container to be seen from the outside. Meanwhile, the mount serves to advertise and decorate the liquid medicine container with letters, designs, etc. printed thereon. Such display items also serve to protect the liquid medicine container. Patent Document 1 discloses this type of display item.

JP 2017-149464 A

However, if a liquid medicine container is opened by tampering at a storefront, the liquid medicine may leak out of the container depending on environmental conditions such as the temperature and humidity. If the lower part of the space in the blister container in which the liquid medicine container is housed is in contact with the liquid medicine container, the liquid medicine may leak out of the container without being noticed, and the surrounding environment in which the exhibit is displayed may be polluted. In addition, if the blister container has a complex structure such as a shell pack, the amount of synthetic resin used increases. Note that the shell pack here refers to a blister container in which two synthetic resin sheets (at least one of which has a bulge that can house a product inside) are connected at their edges and folded back along the edges so that the two sheets face each other.

The present invention aims to provide a display body that makes it easy to check if a liquid medicine has leaked, and a package product that includes the same. In addition, for example, if a complex structure such as a shell pack is not used for the blister part, it is possible to provide an environmentally friendly display body that makes it easy to check if a liquid medicine has leaked, and a package product that includes the same, in which the amount of synthetic resin used is reduced.

The exhibit according to the first aspect of the present invention is an exhibit for displaying a liquid medicine container, and comprises a sheet-like mount having a front and a back, and a blister part made of synthetic resin fixed to the mount. The blister part includes a first bulge that bulges forward from the front of the mount and defines a first space for housing the liquid medicine container therein, and a second bulge that bulges forward from the front of the mount, communicates with the first space below the first space, and defines a second space configured to be large enough that the liquid medicine container housed in the first space cannot enter.

The package product according to the second aspect of the present invention comprises the display body according to the first aspect and the drug solution container housed in the first space.

The packaged product according to the second aspect of the present invention further includes an accessory housed in the second space.

According to the above viewpoint, the blister part includes a first bulge portion that bulges forward from the front of the mount and defines a first space for housing a liquid medicine container inside, and a second bulge portion that similarly bulges forward from the front of the mount and defines a second space below the first space that communicates with the first space. The second space is configured in a shape that the liquid medicine container housed in the first space cannot enter. Therefore, when the liquid medicine container is housed in the exhibit, a space (second space) is secured below the liquid medicine container. This space (second space) can function as a liquid reservoir that collects the liquid medicine if the liquid medicine leaks from the liquid medicine container. Therefore, the user can easily confirm that the liquid medicine has leaked by visually checking the state of the second space. In addition, for example, if a complex structure such as a shell pack is not used for the blister part, the amount of synthetic resin used is reduced, which is environmentally friendly.

1 is an external perspective view of a display unit according to one embodiment of the present invention and a packaged product including the display unit, viewed from the front left side. FIG. 2 is an external perspective view of the packaged product as viewed from the rear right side. Left side view of the packaged product. FIG. 1 is a front view of a product (medicinal solution container) according to an embodiment of the present invention. FIG. FIG. 4 is a front view of the drug solution container with the cover member open. FIG. 13 is a left side view of the drug solution container with the clip attached. Front view of the mount. FIG. 2 is a perspective view of the blister part as viewed from the front left side. FIG. 4 is an external perspective view of the blister part as viewed from the rear right side. FIG. 3 is a diagram showing a state in which the seal member is peeled off from the state shown in FIG. 2 .

Below, we will explain an exhibit according to one embodiment of the present invention and a packaged product that includes the exhibit, with reference to the drawings.

<1. Overview of package product>
1 to 3 show external views of an exhibit 1 according to this embodiment and a package product 100 including the exhibit 1. Fig. 1 is a perspective view of the package product 100 seen from the front left side, Fig. 2 is a perspective view of the package product 100 seen from the rear right side, and Fig. 3 is a left side view of the package product 100. Unless otherwise specified, in the description of the package product 100, the terms up, down, left, right, front (front face), and back (rear face, back surface) are defined as shown in Figs. 1 to 3.

The packaged product 100 includes a product 2 and a display unit 1 that packages the product 2 for display, and is displayed on a display shelf or the like installed in a storefront. The display unit 1 includes a sheet-like backing 4 and a blister part 3 made of synthetic resin that is fixed to the backing 4. The display unit 1 in this embodiment is a freestanding type, and legs 32 that protrude backward are arranged at the bottom of the blister part 3 so as to make the display unit 1 stand up. In addition, a bulging part 33 that bulges forward is arranged on the front of the blister part 3, and the bulging part 33 defines a space S1 (see FIG. 11) for storing the product 2 inside. In this embodiment, the blister part 3 is made of a transparent resin material. Therefore, the product 2 stored in the space S1 defined by the bulging part 33 would normally be visible from the outside, but the product 2 is not shown in FIG. 1 and FIG. 3. The structure of the product 2 and the display unit 1 will be described in detail below.

<2. Configuration of each part>
<2-1. Product (medicinal solution container)>
In this embodiment, the exhibit 1 contains a liquid medicine container as a product 2. Hereinafter, the liquid medicine container may also be given the same reference symbol 2. Figures 4 and 5 show a front view and a back view, respectively, of the liquid medicine container 2. The liquid medicine container 2 is a device that provides various effects of the liquid medicine to the surrounding space by volatilizing the liquid medicine into the surrounding space.

The medicinal liquid used here is not particularly limited in type, but is typically an air freshener, a deodorant, or an insect repellent, or a mixture thereof, and contains additives such as fragrances, deodorant components, insect repellent components, and colorants depending on the purpose of use. The solvent contained in the medicinal liquid is appropriately selected depending on the type of additive used, and can be a hydrophilic solvent, a lipophilic solvent, or a mixture thereof. When the medicinal liquid contains a fragrance, it is preferable that the solvent contains at least a lipophilic solvent in order to increase the fragrance intensity. As the hydrophilic solvent, for example, water or ethanol, or a mixture thereof can be used. As the lipophilic solvent, for example, glycol ether or isoparaffin solvent, or a mixture thereof can be used. In addition, the medicinal liquid may contain a dissolving agent to solubilize functional components such as fragrances, deodorant components, insect repellent components, and colorants.

4 and 5, the liquid medicine container 2 has a container 20 containing the liquid medicine and a cover member 21 that covers the upper part of the container 20. The cover member 21 is configured to be openable and closable, and FIG. 6 shows a front view of the liquid medicine container 2 with the cover member 21 open. As shown in FIG. 6, the container 20 has a mouth portion 201 at its upper part, and an absorbent wick 22 is inserted into the mouth portion 201 so as to extend vertically. The absorbent wick 22 is a member that sucks up the liquid medicine. A cap 23 that covers the mouth portion 201 and the part of the absorbent wick 22 that protrudes upward from the mouth portion 201 is detachably attached to the mouth portion 201. In FIG. 6, the positions of the mouth portion 201 and the absorbent wick 22 that are covered by the container 20 and the cap 23 are indicated by dotted lines. In addition, in this embodiment, the container 20 is configured to be transparent, and its inside would normally be visible from the outside, but the inside of the container 20 is not shown in Figures 4, 5, and 7.

When the cap 23 is attached to the mouth 201, the portion of the absorbent wick 22 exposed upward from the mouth 201 is generally sealed by the cap 23 and is isolated from the external space. Therefore, in this state, the liquid medicine does not evaporate from the absorbent wick 22. Therefore, the cap 23 is attached to the container 20 when the liquid medicine container 2 is not in use, and is removed when it is in use. When the liquid medicine container 2 is in use, the above-mentioned cover member 21 is opened, the cap 23 is removed, and the cover member 21 is closed again. As shown in FIG. 5, a number of volatilization ports 211 are formed on the back and top of the cap 23. Therefore, when the cap 23 is removed, even if the cover member 21 is closed, the liquid medicine begins to evaporate from the absorbent wick 22 impregnated with the liquid medicine into the surrounding space through the above-mentioned volatilization ports 211, and the efficacy of the liquid medicine is exerted.

Although not limited thereto, the liquid medicine container 2 of this embodiment is for use in an automobile and is installed in the vehicle. More specifically, the liquid medicine container 2 is attached to a louver disposed at the air outlet of the vehicle's air conditioner. This allows the liquid medicine container 2 to be carried by the airflow blown out from the air conditioner's outlet and efficiently spread throughout the vehicle. In order to efficiently achieve this, the package product 100 contains a clip 24 shown in FIG. 7 as an accessory to the liquid medicine container 2, together with the liquid medicine container 2. The clip 24 is detachable from the cover member 21 described above, and FIG. 7 shows a left side view of the liquid medicine container 2 with the clip 24 attached to the cover member 21. More specifically, as shown in FIG. 5, an insertion opening 212 into which the base 241 of the clip 24 can be inserted is formed at approximately the center of the back surface of the cover member 21. The base 241 of the clip 24 and the insertion port 212 of the cover member 21 are configured so that when the former is inserted into the latter, the clip 24 is firmly fixed to the cover member 21. The clip 24 has a pair of protruding pieces 242 and 243 that extend rearward from the base 241, and the liquid medicine container 2 is fixed near the air outlet by inserting a louver into the gap between these protruding pieces 242 and 243. In this state, the airflow blown out from the air outlet of the air conditioner enters the inside of the cover member 21 through the above-mentioned volatilization port 211, and is sent out from the inside of the cover member 21 to the surrounding space again through the volatilization port 211 with the liquid medicine on it.

<2-2. Exhibits>
Next, the exhibit 1 will be described. The exhibit 1 has a blister part 3 made of synthetic resin and a mount 4 supported by the blister part 3. Fig. 8 is a front view of the mount 4 alone, and Figs. 9 and 10 are external perspective views of the blister part 3 as seen from the front left and rear right, respectively. The type of resin material constituting the blister part 3 is not particularly limited, but a preferred example is polyethylene terephthalate (PET). The blister part 3 of this embodiment is integrally formed from the same resin material.

The backing 4 is made of a single sheet of cardboard and is formed in the shape of a flat, generally rectangular sheet. On the other hand, the blister component 3 has an uneven shape in the front-to-rear direction. More specifically, the blister component 3 has a flat, sheet-like base surface portion 31 and a bulging portion 33 that rises forward from near the top of the base surface portion 31 and bulges forward. In this embodiment, the base surface portion 31 is formed in the shape of a single-layered sheet. As described above, the bulging portion 33 defines a space S1 for accommodating the drug solution container 2 therein.

The blister part 3 also has legs 32 that rise from near the bottom of the base part 31 toward the rear and extend rearward. As shown in FIG. 2, when the blister part 3 is fixed to the mount 4, the legs 32 are positioned at approximately the same height as the bottom of the mount 4, and together with the bottom of the mount 4, they form the bottom of the exhibit 1. Therefore, the legs 32 extend rearward from the back surface of the mount 4 near the bottom of the mount 4, allowing the package product 100 to stand upright. In this embodiment, the legs 32 also bulge out from the base part 31, similar to the bulging part 33, and a space S3 is formed inside. Therefore, the legs 32 have a bulge and are configured to be large overall despite the small amount of synthetic resin, and as a result, the package product 100 can stand upright more stably.

2 and 10, the leg portion 32 in this embodiment has two long legs 321 and 321 that extend rearward from the vicinity of the left and right ends of the base portion 31. When the package product 100 is in an upright position, the mount 4 and the base portion 31 are in a rearward tilted position that tilts more rearward as it approaches the upper side, and the rear ends of the long legs 321 and 321 contact the display surface. As shown in FIG. 3, each of the long legs 321 is approximately trapezoidal in side view, and has a bottom surface portion 321a that extends horizontally, an upper surface portion 321b that slopes downward as it moves away from the base portion 31 rearward, and a rear surface portion 321c that extends in the vertical direction to connect the rear edges of the bottom surface portion 321a and the upper surface portion 321b. The bottom surface 321a and the top surface 321b each have a flat base surface, and on the base surface, ribs 322a and 322b are formed, respectively, extending in the front-rear direction at approximately the center in the left-right direction. The rear surface 321c also has a rib 322c extending in the up-down direction at approximately the center in the left-right direction, and the rib 322c on the rear surface 321c extends so as to connect the rib 322a on the bottom surface 321a and the rib 322b on the top surface 321b. In this embodiment, the cross section perpendicular to the longitudinal direction of the ribs 322a to 322c is semicircular, but can be configured in various shapes such as a triangular shape or a rectangular shape. The above-mentioned ribs 322a to 322c improve the strength of the long legs 321 and 321, which are particularly subjected to the weight of the packaged product 100, and allow the packaged product 100 to stand up more stably.

In addition to the bulge portion 33 that bulges forward from the base surface portion 31, the blister part 3 has another bulge portion 34 that also bulges forward from the base surface portion 31, as shown in Figures 1 and 3. Hereinafter, these bulge portions 33 and 34 may be distinguished by calling the former the first bulge portion and the latter the second bulge portion. Below the space S1 defined by the first bulge portion 33, the second bulge portion 34 defines a space S2 (see Figure 11) that communicates with the space S1. Hereinafter, these spaces S1 and S2 may be distinguished by calling the former the first space and the latter the second space.

In this embodiment, the front-to-back, left-to-right, and top-to-bottom widths of the liquid medicine container 2 are approximately equal to the front-to-back, left-to-right, and top-to-bottom widths of the first space S1, respectively. In addition, the second space S2, which is connected to the lower part of the first space S1, is thinner from front to back than the first space S1 as shown in FIG. 3, and is also slightly narrower in left-to-right width than the first space S1 as shown in FIG. 1. As a result of the above, the second space S2 is configured in a shape that prevents the liquid medicine container 2 contained in the first space S1 from entering, and the liquid medicine container 2 is generally unable to move within the space S1.

However, if the liquid medicine container 2 is opened, for example, by removing the cap 23 due to some reason such as vandalism at a store, there is a risk that the liquid medicine will leak from the liquid medicine container 2 depending on environmental conditions such as the surrounding temperature and humidity. If the lower part of the space in the blister part 3 in which the liquid medicine container 2 is housed is in contact with the liquid medicine container 2, the liquid medicine container 2 will block the view, and the liquid medicine will be left unnoticed and the surrounding environment in which the exhibit 1 is displayed may be polluted. In contrast, in this embodiment, when the liquid medicine container 2 is housed in the space S1, a space S2 is secured below the liquid medicine container 2. If the liquid medicine leaks from the liquid medicine container 2, the space S2 can function as a liquid reservoir for collecting the liquid medicine. Therefore, the user can easily confirm that the liquid medicine has leaked by visually checking the state of the second space S2.

As described above, the cross-sectional area A2 of the second space S2 is smaller than the cross-sectional area A1 of the first space S1. Here, the smaller the cross-sectional area A2 of the second space S2, the easier it is for the liquid level of the liquid medicine collected in the second space S2 to rise when the liquid medicine leaks from the liquid medicine container 2, making it easier to confirm that the liquid medicine is leaking. From this viewpoint, it is preferable that A2≦(3/4)·A1, it is more preferable that A2≦(2/3)·A1, and it is even more preferable that A2≦(1/2)·A1. It is also preferable that A2≧(1/10)·A1, it is more preferable that A2≧(1/8)·A1, and it is even more preferable that A2≧(1/5)·A1.

In this embodiment, the second space S2 contains a clip 24 as an accessory to the liquid medicine container 2. The presence of the clip 24 in the second space S2 contributes to further raising the liquid level of the liquid medicine that accumulates in the second space S2 when the liquid medicine leaks from the liquid medicine container 2. Therefore, in this embodiment, it becomes even easier to confirm that the liquid medicine is leaking.

As shown in FIG. 8, an opening 40 is formed in approximately the center of the mount 4. The opening 40 is approximately rectangular and approximately matches the shape of the combined space of the first space S1 and the second space S2 when viewed from the front. When the blister component 3 is attached to the mount 4, the bulging portions 33 and 34 are inserted into the opening 40 from the back side of the mount 4 and bulge forward from the front of the mount 4. At this time, the base portion 31 of the blister component 3 is positioned so as to face and contact the back side of the mount 4.

When the bulging portions 33 and 34 of the blister part 3 are inserted into the opening 40 of the backing 4, the spaces S1 and S2 defined by the bulging portions 33 and 34 are open at the rear. The liquid medicine container 2 and the clip 24 are accommodated in the spaces S1 and S2, respectively, through these openings. These openings also serve as removal ports for removing the liquid medicine container 2 and the clip 24 from the spaces S1 and S2.

2 and 11, the spaces S1 and S2 are closed by a sheet-like sealing member 5. FIG. 11 shows the state when the sealing member 5 is peeled off from the state shown in FIG. 2. Note that the clip 24 is not shown in FIG. 11. More specifically, the sealing member 5 is attached to the back surface of the mount 4 around the opening 40 of the mount 4 so as to close the rear outlets of the spaces S1 and S2. At this time, in this embodiment, the sealing member 5 is also attached to the flange portion 311 included in the blister part 3. The flange portion 311 is a part of the base surface portion 31, and is a substantially rectangular ring-shaped portion arranged on the upper part of the base surface portion 31 so as to surround the outlets of the spaces S1 and S2. The flange portion 311 faces the back surface of the mount 4. The above-mentioned bulging portions 33 and 34 rise forward from the inner edge of the flange portion 311.

The sealing member 5 can be peeled off from the back surface of the mount 4 and the flange portion 311, and in this embodiment, is particularly attached to the back surface of the mount 4 and the flange portion 311 in a resealable manner. The sealing member 5 is a member in which an adhesive layer made of an adhesive is laminated in a predetermined area on one side of a sheet body. In this embodiment, the adhesive is applied along the outer periphery of one side of the approximately rectangular sheet body. The material of the sheet body included in the sealing member 5 can be selected as appropriate, and can be made of, for example, paper, cloth, or synthetic resin.

2, the sealing member 5 has a central region 51 that is not adhesive, and a peripheral region 52 that surrounds the central region 51 and has the above adhesive layer formed thereon and has adhesive properties. The peripheral region 52 faces the flange portion 311 and the region surrounding the flange portion 311 on the back surface of the backing paper 4 in the vicinity of the flange portion 311, and is adhered to these. As a result, the sealing member 5 closes the spaces S1 and S2 in which the liquid medicine container 2 and the clip 24 are housed, and fixes the position of the blister part 3 relative to the backing paper 4 by sandwiching the flange portion 311 of the blister part 3 between the sealing member 5 and the backing paper 4. On the other hand, since no adhesive layer is formed in the central region 51 that covers the outlets of the spaces S1 and S2, adhesive does not adhere to the liquid medicine container 2 and the clip 24.

The space S3 defined by the legs 32 is open at the front (see FIG. 9). When the bulges 33 and 34 are inserted into the opening 40 to attach the blister part 3 to the backing 4, the front of the opening of the space S3 is covered by the backing 4. At this time, the flange 312 comes into contact with the back surface of the backing 4. The flange 312 is a part of the base 31, and is a roughly rectangular ring-shaped portion that is located at the bottom of the base 31 so as to surround the front opening of the space S3.

As shown in FIG. 8, an inverted U-shaped notch 41 is formed in the lower part of the mount 4, approximately in the center in the left-right direction. Meanwhile, part 312a (see FIGS. 1 and 9) of flange 312 of blister component 3 that is sandwiched between long legs 321 and 321 functions as an insertion piece that is inserted from above into the notch 41. By inserting part 312a into notch 41, leg 32 is prevented from separating from the back surface of mount 4, improving the ease of assembly of mount 4 and blister component 3. Furthermore, by inserting part 312a of blister component 3 into notch 41, it becomes easier to align the two when attaching blister component 3 to mount 4.

A substantially circular hole 42 is formed in the upper part of the backing 4, approximately in the center in the left-right direction. This allows the packaged product 100 to be displayed not only standing up on a display surface such as a display shelf, but also suspended by hanging the hole 42 on a hook on a display shelf or the like.

The front of the mount 4 is printed with appropriate letters, designs, etc., to advertise, explain, and decorate the liquid medicine container 2. In this embodiment, the legs 32 are positioned on the back side of the mount 4, so that a sufficient printing area can be secured on the front of the mount 4. Note that appropriate letters, designs, etc. can be printed not only on the front of the mount 4, but also on the back of the mount 4.

<3. Features>
<3-1>
In the blister part 3 of the above embodiment, the base surface part 31 is formed in a sheet shape with a single layer structure. Therefore, the amount of synthetic resin used is reduced, which reduces the cost and the environmental load. In addition, since the amount of synthetic resin used in the base surface part 31 is reduced, the thickness of the base surface part 31 as a whole is relatively thin, but the base surface part 31 is divided into a front upper part and a rear lower part, and the bulge part 33 and the leg part 32 are continuous with each other. Therefore, when the leg part 32 is placed on a display surface extending substantially horizontally, the package product 100 can maintain balance in the front-rear direction and the up-down direction, and the package product 100 can stand up stably. In addition, in the above embodiment, the mount 4, which is placed in a backward tilted position while facing the base surface part 31, also contributes to the stable standing of the package product 100.

<3-2>
Conventionally, blister containers have often been attached to mounts by heat welding. However, depending on the type of ink, coating agent, etc. attached to the mount surface, poor welding may occur between the blister container made of synthetic resin, and the specifications of the mount surface have been limited. In this regard, in the above embodiment, the seal member 5 attached to the mount 4 closes the spaces S1 and S2 for accommodating the liquid medicine container 2 and the clip 24, and fixes the blister part 3 to the mount 4. Therefore, the exhibit 1 can be properly assembled without heat welding (or while reducing the number of places to be heat-welded). In addition, in the above embodiment, the legs 32 are arranged on the back side of the mount 4, so the presence of the legs 32 does not limit the specifications of the front side of the mount 4. Therefore, the freedom of configuration of the mount 4 is increased.

<3-3>
In the above embodiment, a space (second space S2) for storing the liquid medicine is provided below the liquid medicine container 2 housed in the exhibit 1. Therefore, when the liquid medicine leaks from the liquid medicine container 2, the user can easily confirm this by visually checking the state of the second space S2.

4. Modifications
Although one embodiment of the present invention has been described above, the present invention is not limited to the above embodiment, and various modifications are possible without departing from the spirit of the present invention. For example, the following modifications are possible. In addition, the gist of the following modifications can be combined as appropriate.

<4-1>
The accessories stored in the second space S2 can be appropriately selected depending on the type of the product 2. Alternatively, nothing may be stored in the space S2.

<4-2>
In the above embodiment, the notch 41 is formed in the lower part of the backing 4, and the insert piece (portion 312a) to be inserted into the notch 41 is formed near the leg portion 32 of the blister part 3. However, the insert piece may be formed in the lower part of the backing 4, and a notch into which the insert piece is inserted may be formed near the leg portion 32 of the blister part 3.

100 Packaged product 1 Exhibit 2 Product (medicinal liquid container)
24 Clip (accessory)
3 Blister component 31 Base part 311 Flange part 32 Leg part 33 Swelling part (first swelling part)
34 Swelling part (second swelling part)
4: mount 5: seal member 51: central region 52: peripheral region S1: space (first space)
S2 space (second space)

Claims (4)

A display for displaying a liquid medicine container,
A sheet-like mount having a front surface and a back surface;
A blister part made of a synthetic resin and fixed to the mount,
The blister part comprises:
a first bulging portion that bulges forward from the front surface of the mount and defines a first space for accommodating the drug solution container therein;
a second bulging portion that defines a second space that bulges forward from the front surface of the mount, communicates with the first space below the first space, and is configured in a shape that prevents the drug solution container contained in the first space from entering;
the first bulge portion and the second bulge portion are in contact with each other,
The first bulge portion and the second bulge portion have openings formed in the entire rear portion.
Exhibit. The mount has an opening formed therein,
the first bulge portion and the second bulge portion are inserted into the opening from the back surface of the mount to define the first space and the second space,
The exhibit according to claim 1 , further comprising a sheet-like sheet member that closes the first space and the second space. The exhibit according to claim 1 or 2,
The drug solution container is accommodated in the first space.
Packaged products. Further comprising an accessory housed in the second space.
The packaged product of claim 3.